Aspen Aerogels (NYSE:ASPN – Get Free Report) was upgraded by equities researchers at TD Cowen to a “strong-buy” rating in a note issued to investors on Tuesday,Zacks.com reports.
ASPN has been the topic of several other research reports. Canaccord Genuity Group dropped their price target on Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating on the stock in a report on Friday, February 14th. Barclays cut their target price on shares of Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating on the stock in a research note on Wednesday, February 19th. StockNews.com raised shares of Aspen Aerogels to a “sell” rating in a research note on Wednesday, February 19th. Roth Mkm dropped their price target on shares of Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating on the stock in a research note on Friday, February 14th. Finally, B. Riley dropped their price target on shares of Aspen Aerogels from $35.00 to $22.00 and set a “buy” rating on the stock in a research note on Wednesday, February 19th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating, eight have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $19.11.
View Our Latest Analysis on Aspen Aerogels
Aspen Aerogels Price Performance
Aspen Aerogels (NYSE:ASPN – Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The construction company reported $0.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. On average, research analysts forecast that Aspen Aerogels will post 0.17 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Aspen Aerogels
A number of large investors have recently bought and sold shares of ASPN. Abbot Financial Management Inc. boosted its holdings in Aspen Aerogels by 3.9% during the fourth quarter. Abbot Financial Management Inc. now owns 30,255 shares of the construction company’s stock valued at $359,000 after acquiring an additional 1,146 shares during the period. Franklin Resources Inc. boosted its holdings in Aspen Aerogels by 5.3% during the third quarter. Franklin Resources Inc. now owns 29,418 shares of the construction company’s stock valued at $815,000 after acquiring an additional 1,483 shares during the period. Invesco Ltd. boosted its holdings in Aspen Aerogels by 3.5% during the fourth quarter. Invesco Ltd. now owns 50,871 shares of the construction company’s stock valued at $604,000 after acquiring an additional 1,724 shares during the period. Greenwood Capital Associates LLC boosted its holdings in Aspen Aerogels by 5.0% during the fourth quarter. Greenwood Capital Associates LLC now owns 36,938 shares of the construction company’s stock valued at $439,000 after acquiring an additional 1,749 shares during the period. Finally, MetLife Investment Management LLC boosted its holdings in Aspen Aerogels by 6.3% during the fourth quarter. MetLife Investment Management LLC now owns 35,782 shares of the construction company’s stock valued at $425,000 after acquiring an additional 2,118 shares during the period. 97.64% of the stock is currently owned by institutional investors.
Aspen Aerogels Company Profile
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Read More
- Five stocks we like better than Aspen Aerogels
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- 3 Dividend Picks Standing Strong as Bond Yields Fall
- Investing in Construction Stocks
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- Are Penny Stocks a Good Fit for Your Portfolio?
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.